跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EBGLYSS SOLUTION FOR INJECTION IN PRE-FILLED PEN 250MG/2ML - HSA Drug Approval Details
Approvals
/
HSA
/
EBGLYSS SOLUTION FOR INJECTION IN PRE-FILLED PEN 250MG/2ML
Approved
THERAPEUTIC
EBGLYSS SOLUTION FOR INJECTION IN PRE-FILLED PEN 250MG/2ML
Eli Lilly and Company
🇸🇬 Health Sciences Authority
Approval Date
May 2, 2025
Approval ID
177f114a8fbe041a
Company
Eli Lilly and Company
Type
Therapeutic
Approval Details
Approval Id
177f114a8fbe041a
Drug Name
EBGLYSS SOLUTION FOR INJECTION IN PRE-FILLED PEN 250MG/2ML
Product Name
EBGLYSS SOLUTION FOR INJECTION IN PRE-FILLED PEN 250MG/2ML
Approval Number
SIN17229P
Approval Date
2025-05-02
Registrant
DKSH SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION
Route Of Administration
SUBCUTANEOUS
Atc Code
D11AH10
Pharma Manufacturer Name
DKSH SINGAPORE PTE. LTD.
Company Detail Path
/organization/dksh-singapore-pte-ltd
Active Ingredients
Lebrikizumab
250 mg/2 mL
Lebrikizumab
250 mg/2 mL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 2, 2025
Approval ID
177f114a8fbe041a
Type
Therapeutic
Back to HSA Approvals
